initial public offerings (IPOs) trading on American exchanges
Showing posts with label THOR. Show all posts
Showing posts with label THOR. Show all posts

Sunday, June 2, 2019

IPOs this week : June 3 - 7, 19 (wk 23)

Analyst quiet period expirations: 
  • Trevi Therapeutics (NASDAQ:TRVI), 
  • Parsons (NYSE:PSN), 
  • HeadHunter (NASDAQ:HHR), 
  • Axcella Health (NASDAQ:AXLA), 
  • NextCure (NASDAQ:NXTC), 
  • Mayville Engineering (NYSE:MEC), 
  • Milestone Pharma (NASDAQ:MIST), 
  • South Plains Financial (NASDAQ:SPFI) and 
  • Cortexyme (NASDAQ:CRTX) on June 3; 
  • Sonim Technologies (NASDAQ:SONM) and 
  • Jiayin (NASDAQ:JFIN) on June 4.

IPO share lockup expirations:
  • Mogu (NYSE:MOGU) on June 4; 
  • Moderna (NASDAQ:MRNA), 
  • Synthorx (NASDAQ:THOR) and DiaMedica (NASDAQ:DMAC) on June 5.

Friday, December 7, 2018

Synthorx (THOR) began trading on the Nasdaq on 7 December 2018

Update Dec 9, 2019:  Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 billion

------

The biopharmaceutical company Synthorx designs proteins for targeted therapeutic modulation of tumors and autoimmune disorders.

Synthorx opened for trading at $15.40 after pricing IPO at $11.
The company issued 9.1 million shares